Silvia Oghina
- Nephrology top 10%
- Parathyroid Disorders and Treatments 14
-
- Cardiomyopathy and Myosin Studies 6
- Atrial Fibrillation Management and Outcomes 2
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 29
-
- IgG4-Related and Inflammatory Diseases 2
- Eosinophilic Disorders and Syndromes 2
-
- Peptidase Inhibition and Analysis 6
-
- Sarcoidosis and Beryllium Toxicity Research 3
- Co-authors
- Thibaud DamyMounira KharoubiMélanie BézardDiane BodezEmmanuel TeígerPascale FanenAlexandre MebazaaArnault Galat
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Silvia Oghina
22 papers receiving 217 citations
Peers
Comparison fields: 5 of 33
- Nephrology 86
- Cardiology and Cardiovascular Medicine 76
- Molecular Biology 178
- Genetics 22
- Rheumatology 24
Countries citing papers authored by Silvia Oghina
This map shows the geographic impact of Silvia Oghina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Oghina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Oghina more than expected).
Fields of papers citing papers by Silvia Oghina
This network shows the impact of papers produced by Silvia Oghina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Oghina. The network helps show where Silvia Oghina may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Silvia Oghina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 23 | |
| 15 | 2021 | 9 | |
| 16 | 2021 | 2 | |
| 17 | 2021 | 8 | |
| 18 | 2021 | 52 | |
| 19 | 2020 | 12 | |
| 20 | 2020 | 17 |
About Silvia Oghina
Silvia Oghina is a scholar working on Nephrology, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 29 papers that have together received 223 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (29 papers), Parathyroid Disorders and Treatments (14 papers), Peptidase Inhibition and Analysis (6 papers), Cardiomyopathy and Myosin Studies (6 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers), IgG4-Related and Inflammatory Diseases (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). The work is most often cited by research in Nephrology (86 citations), Cardiology and Cardiovascular Medicine (76 citations) and Molecular Biology (178 citations). Silvia Oghina has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Thibaud Damy, Mounira Kharoubi, Mélanie Bézard, Diane Bodez, Emmanuel Teíger, Pascale Fanen, Alexandre Mebazaa, Arnault Galat, Michel Komajda and Soulef Guendouz. Their work appears in journals such as ESC Heart Failure, Journal of Clinical Medicine, Amyloid, Journal of the American Heart Association and Mayo Clinic Proceedings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.